249 Shares in Axon Enterprise, Inc $AXON Purchased by Rehmann Capital Advisory Group

Rehmann Capital Advisory Group acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 249 shares of the biotechnology company’s stock, valued at approximately $206,000.

Several other large investors also recently bought and sold shares of the business. LaSalle St. Investment Advisors LLC lifted its holdings in Axon Enterprise by 2.1% during the first quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company’s stock valued at $408,000 after purchasing an additional 16 shares in the last quarter. Hemington Wealth Management lifted its holdings in Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after purchasing an additional 17 shares in the last quarter. Smartleaf Asset Management LLC lifted its holdings in Axon Enterprise by 5.0% during the first quarter. Smartleaf Asset Management LLC now owns 379 shares of the biotechnology company’s stock valued at $203,000 after purchasing an additional 18 shares in the last quarter. WCM Investment Management LLC lifted its holdings in Axon Enterprise by 0.8% during the first quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company’s stock valued at $1,306,000 after purchasing an additional 19 shares in the last quarter. Finally, Sheaff Brock Investment Advisors LLC lifted its holdings in Axon Enterprise by 0.5% during the first quarter. Sheaff Brock Investment Advisors LLC now owns 3,561 shares of the biotechnology company’s stock valued at $1,873,000 after purchasing an additional 19 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms have weighed in on AXON. Piper Sandler began coverage on Axon Enterprise in a research note on Tuesday, September 23rd. They issued an “overweight” rating and a $893.00 price target for the company. Morgan Stanley set a $885.00 target price on shares of Axon Enterprise and gave the stock an “overweight” rating in a research report on Friday, July 11th. Craig Hallum raised shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 target price for the company in a research note on Tuesday, August 5th. Weiss Ratings reiterated a “hold (c)” rating on shares of Axon Enterprise in a research note on Friday. Finally, Northland Securities set a $800.00 price objective on Axon Enterprise in a research report on Tuesday, August 5th. Fourteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $841.64.

Insider Activity

In other news, Director Hadi Partovi acquired 1,358 shares of the business’s stock in a transaction on Wednesday, August 13th. The shares were acquired at an average price of $740.00 per share, for a total transaction of $1,004,920.00. Following the completion of the transaction, the director directly owned 237,938 shares of the company’s stock, valued at approximately $176,074,120. The trade was a 0.57% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Monday, August 11th. The shares were sold at an average price of $831.29, for a total transaction of $8,312,900.00. Following the completion of the sale, the chief executive officer directly owned 3,053,982 shares in the company, valued at approximately $2,538,744,696.78. This represents a 0.33% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 59,932 shares of company stock worth $45,115,616. Company insiders own 4.40% of the company’s stock.

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $735.95 on Friday. The company’s 50-day moving average price is $733.17 and its 200-day moving average price is $723.75. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. The company has a market cap of $57.78 billion, a PE ratio of 181.72, a price-to-earnings-growth ratio of 27.82 and a beta of 1.41. Axon Enterprise, Inc has a twelve month low of $422.38 and a twelve month high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The firm had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. During the same quarter last year, the firm earned $1.20 EPS. The firm’s revenue for the quarter was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. On average, equities research analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.